International journal of cardiology
-
Transcatheter aortic valve replacement (TAVR) has emerged as an alternative to surgical aortic-valve replacement (SAVR) for patients with severe symptomatic aortic stenosis (AS) who are at high operative risk. We sought to determine the long-term (≥1year follow-up) safety and efficacy TAVR compared with SAVR in patients with severe AS. ⋯ TAVR and SAVR showed similar long-term survival in patients with severe AS; with important differences in treatment-associated morbidity.